MIRM
Mirum Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$85.69
−0.81%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 41.80x
- P/S forward
- 7.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -533.87x
- Price / sales
- 9.00x
- Price / cash flow
- -12.20x
Enterprise value
- Enterprise value
- $5.9B
- EV / sales
- 9.52x
- EV / EBITDA
- -7.58x
- EV / EBIT
- -54.67x
- Market cap
- $5.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026